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Abstract In a comparison of embryonic brain expression pat-
terns of lysophosphatidic acid and sphingosine 1-phosphate re-
ceptor genes (lpa13 and s1p15, respectively), transcripts de-
tected by Northern blot were subsequently localized using in
situ hybridization. We found striking s1p1 expression adjacent
to several ventricles. Near the lateral ventricle, s1p1 expression
was temporally and spatially coincident with neurogenesis and
overlapped with lpa1 in the neocortical area. We also observed a
widespread di¡use pattern for lpa23 and a scattered punctate
pattern for s1p13. The punctate pattern colocalized with vas-
cular endothelial markers. Together, these results suggest that
s1p1 in£uences neurogenesis and s1p13 in£uence angiogenesis
in the developing brain.
( 2002 Published by Elsevier Science B.V. on behalf of the
Federation of European Biochemical Societies.
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1. Introduction
Lysophosphatidic acid (LPA) and sphingosine 1-phosphate
(S1P) are bioactive lysophospholipids widely distributed in
mammalian tissues [1,2]. Three G-protein coupled receptors
mediate cellular responses to LPA (termed LPA13, or, for-
merly, LPA13, or Edg2, Edg4, and Edg7, respectively), and
¢ve similar receptors mediate cellular responses to S1P
(termed S1P15, also termed LPB13, LPC1, and LPB4, or
Edg1, Edg5, Edg3, Edg6, and Edg8, respectively [3,4]). There
are many cellular responses to LPA and S1P, including in-
creased proliferation, suppression of apoptosis, neurite retrac-
tion, cell rounding, and cell migration [4^7]. Based on cellular
responses and receptor expression patterns it has been pro-
posed that LPA and S1P are involved in wound healing, neu-
rogenesis, angiogenesis, and tumorigenesis [4^8].
Several LPA receptor genes are expressed in the embryonic
brain. The ¢rst lysophospholipid receptor gene identi¢ed, lpa1,
was shown to have speci¢c expression in the ventricular zone
of the mouse embryonic cerebral cortex during the period of
neurogenesis [9]. This suggested a role for lpa1 in nervous
system development that was subsequently con¢rmed in dele-
tion mutant mice [10]. Transcripts of the two additional LPA
receptor genes, lpa2 and lpa3, were found in the embryonic
mouse brain using Northern blots and RT-PCR [11,12]. How-
ever, no in situ hybridization localization data exist, so spe-
ci¢c brain regions potentially a¡ected by lpa2 and lpa3 are not
known.
Likewise, little is known regarding the expression of S1P
receptors in the embryonic mouse brain. It is likely that the
s1p1 transcript is present in the embryonic telencephalon
based on L-galactosidase activity in mutant mice in which
lacZ replaced the normal open reading frame [13]. Also, the
zebra ¢sh s1p1 homolog was expressed in the optic stalks,
hypothalamus, hindbrain, and adjacent to several ventricles
[14]. The s1p2 transcript was found in the rat embryonic brain
using Northern blot [15], and immunohistochemistry localized
the protein to neurons [16]. In addition, while the s1p3 tran-
script was localized by in situ hybridization to the embryonic
mouse choroid plexus [17] and dot blots showed a very faint
expression of s1p4 in the human fetal brain [18], little is
known regarding s1p5 expression in the embryonic brain.
No comparative analysis of the expression of all s1p genes
in embryonic brain currently exists.
In this study, we ¢rst used Northern blots to determine
which of the s1p receptor transcripts were expressed in the
embryonic mouse brain (data on lpa transcripts have already
been published [12]). We then used in situ hybridization to
localize the lpa and s1p gene transcripts that showed prom-
inent expression with Northern blots. The results suggest po-
tential roles for lysophospholipid receptors in both neurogen-
esis and angiogenesis within the developing brain.
2. Materials and methods
2.1. Materials, animals, and tissue processing
Unless otherwise noted, chemicals were purchased from Sigma.
Three-month-old male (for Northern blots) or timed-pregnant female
(for in situ hybridizations) BALB/c mice were purchased from Charles
River Laboratories and sacri¢ced by cervical dislocation. The day
after vaginal plug was designated the ¢rst embryonic day. Embryos
were fresh-frozen in Tissue-Tek OCT compound (Sakura) and tissue
sections were prepared as previously described [19]. Animal protocols
conformed to NIH guidelines and were approved by the University of
California, San Diego Animal Subjects Committee.
2.2. Northern blots, riboprobe preparation, and in situ hybridization
Northern blots were prepared and analyzed as described previously
[12], using DNA fragments containing coding regions from each s1p
gene. For riboprobe synthesis, linearized plasmids containing coding
regions of mouse lpa13, s1p13, platelet/endothelial cell adhesion mol-
ecule-1 (PECAM-1), and CD34 were transcribed in sense and anti-
sense directions using T7, T3, or SP6 (PECAM-1 sense only) RNA
polymerase [9,11,12,20^23]. Hybridization of digoxigenin-labeled ribo-
probes and visualization using an alkaline phosphatase-conjugated
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anti-digoxigenin antibody (Roche) were performed as previously de-
scribed [24]. Sections were subsequently counterstained using 0.35 Wg/
ml DAPI (4P,6-diamino-2-phenylindole).
2.3. Double-labeling studies
For bromodeoxyuridine (BrdU) labeling and in situ hybridization,
1 h prior to sacri¢ce, timed-pregnant BALB/c mice were intraperito-
neally injected with 20 Wl 10 mM BrdU per gram body weight. Tissues
were processed and in situ hybridization carried out as described
above, then sections were processed for BrdU labeling as previously
described [9].
2.4. Double in situ hybridization labeling
For double in situ hybridization labeling, £uorescein-labeled s1p1 or
s1p3 riboprobes and digoxigenin-labeled CD34 or PECAM-1 ribo-
probes were used. Sections hybridized with both probes were washed
as described above and processed sequentially per the TSA Plus Fluo-
rescein System and TSA Cyanine 3 System protocols (New England
Nuclear). Sections were subsequently counterstained with DAPI. Both
anti-digoxigenin and anti-£uorescein POD antibodies (Roche) were
used at a concentration of 1:2000.
3. Results
3.1. Northern blots demonstrate s1p13 expression in embryonic
brain
Northern blots were used to determine whether s1p genes
were expressed in the embryonic mouse brain. Total brain
RNA from embryonic days (E) 14, 16, and 18, as well as
control adult tissues, were probed with unique DNA frag-
ments from each s1p gene cDNA (Fig. 1). We found a high
expression level of s1p1 and lower but clearly detectable ex-
pression levels of s1p2 and s1p3 at each age. There was no
detectable s1p4 and only a barely detectable level of s1p5.
These results suggested that s1p13 genes, in addition to
lpa13 genes [11,12], may play roles in embryonic central ner-
vous system (CNS) development.
3.2. In situ hybridization reveals distinct expression patterns for
lysophospholipid receptors in embryonic brain
To compare spatial patterns of prenatal mouse brain ex-
pression of lysophospholipid receptor genes, parasagittal
E14 embryonic brain sections were examined by in situ hy-
bridization. One striking pattern of expression, observed for
lpa1 and s1p1, was in bands of cells adjacent to one or more
Fig. 1. Northern blots probed for s1p genes. Total RNA blots
(20 Wg per lane) are shown from adult lung, kidney, and liver (con-
trols; left panel); and E14, E16, and E18 whole mouse brain (right
panel). Molecular weight marker sizes and positions are indicated to
the left. A cyclophilin probe was used to demonstrate mRNA load-
ing quantity.
Fig. 2. E14 embryonic mouse brain localization of lpa receptors in sagittal sections. Signal for lpa1 delimits meninges (small arrow) and the
neocortical ventricular zone (VZ, large arrow), and is also obvious in the nasal cavity (NC) and vestibulocochlear ganglion (VIII). Signal for
lpa2 extends di¡usely throughout the CNS, and is also apparent in the vestibulocochlear ganglion, trigeminal ganglion (V), and choroid plexus
(arrowhead) of the lateral ventricle (LV). Like lpa2, signal for lpa3 also extends di¡usely throughout the CNS and is apparent in the trigeminal
ganglion. The lower right panel shows a section hybridized with a sense lpa2 probe as a negative control. Scale bar, 500 Wm, d=dorsal, r = ros-
tral.
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ventricles (Figs. 2 and 3). By the lateral ventricle, both lpa1
and s1p1 overlapped in the ventricular zone of the neocortex.
However, s1p1 also extended into the hippocampal primordia,
olfactory bulb, and ganglionic eminence (Fig. 3). In addition,
s1p1 was expressed adjacent to the mesencephalic vesicle and
the fourth ventricle, and in a band of pretectal area cells
(Fig. 3). We also observed lpa1 in putative meninges, as pre-
viously shown [9].
A second pattern characterized lpa2 and lpa3, where di¡use
expression was found in cells throughout the brain (Fig. 2).
For lpa2, relatively low signal intensity was apparent in the
ganglionic eminence compared to cortex, midbrain, and hind-
brain (Fig. 2), with more intense labeling present in the super-
¢cial cortical layers.
A third punctate expression pattern in scattered cells char-
acterized s1p13 (Fig. 3). For s1p1 and s1p3, these signals were
relatively intense and scattered throughout the brain, while for
s1p2, they were fainter and most easily discerned in the mid-
brain/diencephalon region. Also found for all three s1p tran-
scripts was expression in the choroid plexus of the fourth
ventricle, and the putative meninges between the telencepha-
lon and diencephalon.
Outside of the CNS, several other expression areas were
evident. In the nasal cavity, transcripts for all six of the exam-
ined receptors were found. In addition, lpa1 and lpa2 were
found in the vestibulocochlear ganglion, and lpa2 and lpa3
in the trigeminal ganglion.
3.3. Cellular localization of s1p1 mRNA in proliferating cell
populations in prenatal mouse brain
The expression of s1p1 in the ventricular areas of the E14
mouse brain suggested that it delineated neuroproliferative
zones. In order to determine if the s1p1 transcript selectively
colocalized with proliferating cells, sections were prepared
from E14 embryos pulsed for 1 h with BrdU, a thymidine
analog incorporated into newly synthesized DNA (i.e. prolif-
erating cells in S-phase).
Two patterns were observed in sections stained for both
BrdU and s1p1. The ¢rst pattern, observed in the ventricular
zone of the cerebral cortex and ganglionic eminence, is one
where the BrdU and s1p1 signals overlapped (Fig. 4A), and
was highly evident in the hippocampal primordia (Fig. 4C). A
second pattern of BrdU and s1p1 labeling was observed near
the fourth ventricle and mesencephalic vesicle. Here, the BrdU
labeling and the s1p1-expressing cells were largely segregated,
with s1p1 label located more rostrally (Fig. 4B,D).
3.4. Temporal colocalization of s1p1 mRNA with proliferating
cell populations in prenatal mouse brain
To further determine the temporal extent of s1p1 expression
in the cerebral cortical proliferative zone, we examined para-
sagittal sections at four developmental time points : E12, E14,
E16, and E18 (Fig. 5). Similar to lpa1 expression [9], s1p1
expression in the neurogenic ventricular zone progressively
decreased in expression level at E16 and E18. By E18, when
neurogenesis had largely ceased, s1p1 expression was barely
detectable.
3.5. Cellular localization of s1p1 mRNA in blood vessels of
prenatal mouse brain
The punctate expression pattern of s1p13 in prenatal brain
parenchyma, their expression in the choroid plexus, as well as
their established association with endothelial cells [7], sug-
gested that they might be localized to developing blood ves-
sels. In order to test this hypothesis, we ¢rst stained sections
for expression of the endothelial-speci¢c genes, CD34 or PE-
CAM-1, which have previously been shown to localize to em-
bryonic vasculature [22,23]. As expected, a similar punctate
Fig. 3. E14 embryonic mouse brain localization of s1p receptors in sagittal sections. Signal for s1p1 delimits the ventricular zone (VZ, large ar-
row) around the lateral ventricle extending into the hippocampal region (H), olfactory bulb (OB), and ganglionic eminence (GE). Intense s1p1
signal is also seen by the mesencephalic vesicle (MV) and fourth ventricle (IV), denoted by two lower arrowheads. The uppermost arrowhead
denotes the pretectum. Insets show magni¢ed views of part of the diencephalon (D) and demonstrate punctate s1p13 signals in scattered cells
(a small box in the s1p2 panel depicts magni¢cation region and insets in other panels are chosen from a similar position in the diencephalon).
Signals for s1p13 are also present in the choroid plexus (CP) of the fourth ventricle and in meninges (small arrows). Lower right panel shows
£uorescence image of DAPI-stained section. Scale bars, 500 Wm low magni¢cation view; 100 Wm insets, LV= lateral ventricle.
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prenatal mouse brain expression pattern was observed, with
sparse distribution in the ventricular areas (Fig. 6A). Next, we
examined sections for expression of both s1p1 and CD34 using
double in situ hybridization, which demonstrated coexpres-
sion of s1p1 and CD34 throughout the brain and body (not
shown) of the embryo (Fig. 6B^D). Double labeling similarly
demonstrated colocalization of s1p3/CD34, s1p1/PECAM-1,
s1p3/PECAM-1, and s1p1/s1p3 (data not shown).
4. Discussion
One of the most intriguing ¢ndings here is the prominent
cerebral cortical proliferative zone expression of s1p1, which is
temporally coincident with the period of neurogenesis and
with the expression of lpa1. What might the S1P1 receptor
be doing in the cerebral cortical ventricular zone? Several
possibilities can be gleaned from studies of S1P1-receptor
mediated signaling in cells in culture. Stimulation of the
S1P1 receptor activates the Gi=o subfamily of G proteins,
which leads to at least three responses in ¢broblast/endothelial
cells: increased proliferation, suppression of apoptosis, and
cell migration [4,7]. In the embryonic cerebral cortex, neuro-
blast proliferation, apoptosis, and migration of postmitotic
neurons into the cortical plate are all normal developmental
events [25,26]. The S1P1 receptor may be regulating one or
more of these processes. Furthermore, there may be interac-
tions between LPA and S1P in the neocortical ventricular
zone, since lpa1 expression temporally and spatially overlaps
with s1p1 here.
We also found prominent s1p1 expression in the ventricular
areas of the mesencephalon, in areas that give rise to the
superior/inferior colliculi and pons. While it is possible that
s1p1 is a¡ecting proliferation in these regions, at least at E14 it
is more likely playing a role in cell migration and/or survival
because s1p1 expression was segregated from BrdU labeling in
these areas. The functions of s1p1 in ventricular areas are
presumably conserved across vertebrates, since ¢sh embryos
also show ventricular s1p1 expression [14]. One would thus
expect an abnormal brain phenotype in animals with s1p1
Fig. 4. Combined BrdU labeling and s1p1 in situ hybridization in
sagittal E14 sections. A: In the cortical ventricular zone by the lat-
eral ventricle (LV), BrdU signal (gold) is apparent in a band of
basal cells overlapping s1p1 signal (purple), which is easily discerned
in the boxed region of the hippocampal primordia at high magni¢-
cation (C). B: In contrast, regions by the mesencephalic vesicle
(MV) and fourth ventricle (IV) display BrdU signal largely segre-
gated from s1p1 signal, apparent in the boxed region at high magni-
¢cation (D). Scale bars, 300 Wm (A,B), 30 Wm (C,D).
Fig. 5. Temporal expression of s1p1 in cerebral cortex. Sagittal sec-
tions through the neocortex of E12 (A,B), E14 (C,D), E16 (E,F)
and E18 (G,H) embryos showing localization of s1p1 riboprobe
(A,C,E,G) and DAPI £uorescence (B,D,F,H). Note that s1p1 signal
in the ventricular zone (VZ) is high at E12 and E14, moderate at
E16, and minimal at E18. The arrow in C denotes punctate expres-
sion in the cerebral cortical preplate. MZ, marginal zone; CP, corti-
cal plate; IZ, intermediate zone. Scale bar, 300 Wm, d=dorsal,
r = rostral.
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deletions. Unfortunately, analysis of the nervous system in
s1p1(3/3) mice is complicated because they die embryonically
before most neurons are generated [13].
The colocalization of blood vessel markers with the punc-
tate expression pattern of s1p1 and s1p3, as well as the expres-
sion of these receptors in highly vascular choroid plexus, is
consistent with previous ¢ndings indicating functions for S1P
signaling in angiogenesis and vascular maturation [7]. First,
s1p1 expression is dramatically increased when endothelial
cells are induced to di¡erentiate in vitro [27]. Second, both
S1P1 and S1P3-regulated signaling pathways were shown to be
required for endothelial cell morphogenesis into capillary-like
networks, as well as for adhesion and migration [28,29].
Third, the embryonic lethality in s1p1(3/3) mice was due to
a blood vessel maturation defect [13]. Thus, the ¢nding of s1p1
and s1p3 expression in developing brain blood vessels suggests
that S1P signaling is critical for normal angiogenesis in the
embryonic brain.
Although we did not speci¢cally attempt to colocalize s1p2
transcript with blood vessel markers (due to the faint s1p2
signal), its expression in a punctate pattern and in the choroid
plexus suggests that it too is localizing to embryonic blood
vessels. We did not observe an embryonic neuronal expression
pattern of the mouse s1p2 transcript like that observed for
S1P2 protein in the rat [16]. This is consistent with the obser-
vation that s1p2(3/3) mice show no developmental CNS ab-
normalities [30,31], and might re£ect a very low transcript
level in embryonic neurons or be attributable to rat^mouse
species di¡erences. The latter explanation is not unprece-
dented, since rat and mouse have been shown to express dif-
ferentially two lysophospholipid receptor genes (lpa1 and lpa3)
in cultured microglia [32].
Our in situ hybridization data have con¢rmed the expres-
sion of lpa1 in the neocortical ventricular zone and meninges
and have additionally demonstrated expression in the nasal
cavity. This novel ¢nding may have relevance to the de¢cient
suckling behavior in lpa1(3/3) neonatal mice, a behavior that
is likely due to defects in olfactant perception [10].
The roles of LPA and S1P signaling in the developing ner-
vous system are emerging. Determination of the precise spa-
tial and temporal expression pro¢les of each receptor gene
member gives clues as to where one might expect aberrant
function should the gene be inactivated. Our results implicate
s1p1 in cerebral cortical neurogenesis and midbrain develop-
ment, as well as s1p1, s1p2, and s1p3 in brain angiogenesis.
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